Press release
22.03.2021 To the attention of interested persons EMA press release: EMA advises against use of ivermectin for the prevention or […]
Press release
18.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible […]
Press release
15.03.2021 To the attention of interested persons EMA press release: Review of thalassaemia medicine Zynteglo started. download document …
Press release
15.03.2021 To the attention of interested persons EMA press release: EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and […]
Press release
11.03.2021 To the attention of interested persons EMA press release: EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU. […]
Press release
11.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine Janssen (COVID-19 vaccine (Ad26.COV2-S [recombinant])). download document …
Press release
11.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of Eli Lilly antibodies bamlanivimab and […]
Press release
11.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue […]
Press release
11.03.2021 To the attention of interested persons EMA press release: Reflection paper on the regulatory requirements for vaccines intended to […]
Press release
04.03.2021 To the attention of interested persons EMA press release: EMA review of regdanvimab for COVID-19 to support national decisions […]